NCT01008956View on ClinicalTrials.gov

Safety and Immune Response of One-Dose of Candidate H1N1 Influenza Vaccine GSK2340274A in Adults

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 30, 2010

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Influenza
Interventions
BIOLOGICAL

GSK Biologicals' investigational H1N1 Influenza Vaccine - GSK2340274A

Intramuscular injection, one dose

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01008956 - Safety and Immune Response of One-Dose of Candidate H1N1 Influenza Vaccine GSK2340274A in Adults | Biotech Hunter | Biotech Hunter